Citron’s Andrew Left Tight-Lipped On Valeant Position

Updated on


Citron Research executive editor Andrew Left, explains his trading is not relevant to the Valeant story.

Citron’s Andrew Left tight-lipped on Valeant position

Citron’s Left: I put out info that was true

Citron Research executive editor Andrew Left, addresses Valeant Pharmaceuticals’ critical response to his report on the company.

Citron: Not contacted by SEC

Citron Research executive editor Andrew Left, discusses the company’s strategy with the Valeant story and the Enron analogy.

Citron: Valeant should be the focus, not us

Citron Research executive editor Andrew Left, discusses the company’s strategy with the Valeant story in an effort to walk away from the story.

Citron: Easier to pass Citron story to mainstream media

Citron Research executive editor Andrew Left, discusses the company’s strategy with the Valeant story.

Leave a Comment